SFB 1123 Atherosclerosis-Mechanisms and Networks of Novel Therapeutic Targets

Breadcrumb Navigation



The newly established Collaborative Research Center (CRC) 1123 ‘Atherosclerosis – Mechanisms and Networks of Novel Therapeutic Targets’, funded by the German Research Foundation (DFG), are now offering

  • 12 Postdoc Positions
  • 15 PhD Positions within a Structured PhD Program
  • 5 Lab Technicians

Applications should be sent not later than October 1, 2014 by email to:

Prof. Dr. Christian Weber, Speaker of the CRC 1123
Institute for Cardiovascular Prevention, University Hospital
Ludwig-Maximilians-Universität (LMU) München
Pettenkoferstraße 9
80336 Munich

Email: sfb1123@med.uni-muenchen.de

Successful candidates will employ state-of-the-art experimental approaches and new technologies for optoacoustic and super-resolution imaging as well as an array of transgenic mouse models of conditional gene deletion and knockin insertion of mutants to systematically elaborate intricately linked molecular mechanisms for different target families (cytokines, signal proteins, nucleic acids and lipid mediators). We will propagate the validation of newly identified targets implementing harmonized model systems and bio-informatics network analyses to map the pathogenic complexity and the interaction of new molecular mechanisms. PhD students will benefit from a structured training program. More information on the CRC 1123, principal investigators and individual projects you will find on this webpage.

The Ludwig-Maximilians-Universität is committed to a family-oriented policy and an equal opportunity employer specifically welcoming applications from female scientists. Part time employment is possible. Handicapped persons with similar qualifications will be given priority. We are looking to fill the positions as soon as possible.